Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8361467B2 · kind B2 · utility
4Cited by
43References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2003 |
| Grant date | Jan 29, 2013 |
| Priority date | — |
| Expiry date | Dec 25, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to trans-capsularly administering into a diseased joint a high specificity antagonist selected from the group consisting of:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.